Amanote Research
Register
Sign In
Immunooncology: Can the Right Chimeric Antigen Receptors T-Cell Design Be Made to Cure All Types of Cancers and Will It Be Covered?
Journal of Pharmaceutics
doi 10.1155/2017/7513687
Full Text
Open PDF
Abstract
Available in
full text
Date
January 1, 2017
Authors
Regina Au
Publisher
Hindawi Limited
Related search
214. Design of Multifunctional Chimeric Antigen Receptors for T Cell Cancer Immunotherapy
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Relapsing T-All Can Be Second Disease
Cancer Discovery
Oncology
All That Ever Will Be …
Journal of the American Water Works Association
Water Science
Chemistry
Technology
All Space Will Be Public Space
IEEE Security and Privacy
Computer Networks
Electronic Engineering
Law
Electrical
Communications
Chimeric Antigen Receptors for T Cell Immunotherapy: Current Understanding and Future Directions
Journal of Gene Medicine
Molecular Medicine
Drug Discovery
Genetics
Molecular Biology
Effectiveness of Chimeric Antigen Receptor T Cells May Be Impaired by Prior Chemotherapy
Cancer
Cancer Research
Oncology
Arabidopsis thalianaPattern Recognition Receptors for Bacterial Elongation Factor Tu and Flagellin Can Be Combined to Form Functional Chimeric Receptors
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
CML Hematopoietic Stem Cells Expressing IL-1RAP Can Be Targeted by Chimeric Antigen Receptor (CAR)-engineered T Cells
Cancer Research
Cancer Research
Oncology
Osteoporosis: Can It Be Related to Silicosis?
Tuberkuloz ve Toraks
Pulmonary
Critical Care
Respiratory Medicine
Surgery
Intensive Care Medicine
